What can we learn from negative clinical trials in systemic sclerosis?
Veale
Douglas J
DJ
D015415:Biomarkers / Q000378:metabolism; D002986:Clinical Trials as Topic / Q000379:methods*; D005355:Fibrosis / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000276:immunology; D017211:Treatment Failure
D015415:Biomarkers; D007166:Immunosuppressive Agents